Skip to main content
. Author manuscript; available in PMC: 2022 Jan 1.
Published in final edited form as: J Am Geriatr Soc. 2020 Sep 25;69(1):255–263. doi: 10.1111/jgs.16836

Table 2.

Association and Study Quality Based on the REMARK Checklist and Newcastle Ottawa Scale (NOS) for Selected ATN-(X) Biomarkers

Study Quality
REMARK NOS
Biomarker Low Medium High Low Medium High
Amyloid (A) biomarkers
Fluid-based amyloid 0/0 2/3 1/1 0/0 0/0 3/4
Amyloid Plaques 0/1 0/2 0/1 0/1 0/3 0/0
Tau (T) biomarkers
Phosphorylated tau 0/0 0/1 0/0 0/0 0/0 0/1
Neurofibrillary tangles 0/1 0/1 0/1 0/1 0/2 0/0
Neurodegenerative (N) biomarkers
Neuron Specific Enolase (NSE) 2/3 2/5 1/1 1/2 4/5 0/2
Neurofilament Light (NFL) 0/0 1/1 1/1 0/0 1/1 1/1
Total Tau 0/0 2/2 0/1 0/0 0/1 2/2
Atrophy or hypometabolism 0/0 2/2 2/2 0/0 4/4 0/0
Inflammatory
IL-1β 1/5 1/11 1/2 1/1 1/13 1/5
IL-6 5/8 11/19 2/4 4/4 7/17 7/10
IL-8 1/9 11/25 3/3 0/2 9/23 6/12
IL-10 0/4 2/9 1/2 0/1 2/9 1/5
CRP 4/10 12/20 6/7 0/4 10/19 11/14
S100B 1/5 5/9 3/5 1/5 3/6 5/8
TNFα 0/5 2/13 1/1 3/19 0/0 0/0
Vascular
Post-mortem lesions 0/0 0/1 0/1 0/0 0/2 0/0
MRI 0/0 1/1 2/3 0/0 3/4 0/0
Synucleinopathy 0/0 0/1 0/1 0/0 0/2 0/0
EC-CAM 0/0 0/1 0/0 0/0 0/1 0/0
Synaptic Function
EEG 4/4 6/7 3/3 2/2 4/5 7/7
Bispectral EEG 2/2 2/3 0/0 0/0 4/5 0/0
fMRI 0/0 2/3 0/0 2/2 0/1 0/0

EEG = electroencephalogram; fMRI = functional magnetic resonance imaging

The numerator represents number of studies that found an association between biomarker and delirium. The denominator represents the number of studies in that category of study quality.

The REMARK (Reporting Recommendations for Tumor Marker Prognostic Studies) checklist is scored on a range of 0–25 checklist score, and categorized as L = low, < 12.5 points; M = moderate, 12.5–18.75 points; H = high > 18.75 points. The Newcastle Ottawa Scale (NOS) score has a range of 1–9 and was categorized as L = low, < 5 points; M = moderate, 5–7 points; H = high, > 7 points.